Trend Screener

Aurobindo Pharma Share Price AUROPHARMA

Aurobindo Pharma Limited
Open Chart
₹1,627.50
+2.36%
Today High / Low ₹1,635.00 / ₹1,597.20
52W High / Low ₹1,740.00 / ₹1,091.20
Trend Screener Score 52%  |  Neutral

AUROPHARMA Trend Matrix

Monthly Trend Bullish / Sup.. - ₹1,586.90
Weekly Trend Bearish / Res.. - ₹1,662.10
Daily Trend Bearish / Res.. - ₹1,607.70
Hourly Trend Bearish / Res.. - ₹1,627.90
15M Trend Bearish / Res.. - ₹1,630.00
CMP vs S/R NO

RSI Momentum Values

Monthly RSI 67.15
Weekly RSI 56.10
Daily RSI 46.73

Moving Average Confluence (SMA)

SMA 200 ₹1,463.73
SMA 100 ₹1,611.40
SMA 50 ₹1,662.44
SMA 20 ₹1,651.71
SMA 10 ₹1,622.94
Overall Trend: Trend is currently mixed and consolidating, with the price moving sideways without a clear direction either way.

Momentum: RSI is around 56.66, which gives buyers a slight edge. A stronger move above this level would improve momentum further. Short-term charts also remain bearish, which suggests that selling pressure is still present.

Moving Averages: Price is trading around the major moving averages. This usually indicates that the stock is moving sideways and waiting for a clear direction. However, the price is still above the 200-day SMA, which keeps the long-term trend positive.

Key Levels: The next major support is near ₹1,586.90. The nearest resistance is around ₹1,662.10. Today's range has been between ₹1,597.20 and ₹1,635.00. The stock is trading in the upper part of its 52-week range, which reflects good long-term strength.

Trend Summary: Neutral. The stock is not showing a clear direction at the moment. Waiting for a breakout or breakdown is a better approach.
Market Capitalisation See Ratios Below ↓
Key Statements See Ratios Below ↓

About Aurobindo Pharma

Aurobindo Pharma Limited is a pharmaceutical company engaged in the development, manufacture and sale of generic medicines, active pharmaceutical ingredients and injectable products. Its portfolio includes oral formulations, injectables, vaccines, biosimilars and pharmaceutical ingredients across therapeutic areas such as cardiovascular care, respiratory diseases, diabetes, gastroenterology, oncology and dermatology. The company operates across India, the United States, Europe and other international markets. Incorporated in 1986, Aurobindo Pharma is headquartered in Hyderabad, India.

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Website: Official Website

Similar Stocks (NIFTY 100 Peers)

Aurobindo Pharma Limited (Aurobindo Pharma) Share Price & Technical Analysis

Track the latest Aurobindo Pharma Limited share price along with important technical indicators in one place. This page provides a quick overview of the stock's current trend, momentum, and key price levels without switching between multiple charts.

You can check the live market price, Monthly, Weekly, Daily and Intraday trends, RSI values, Moving Averages (SMA), support & resistance levels, and the stock's 52-week high and low to better understand its overall market position.

Trend Screener automatically updates market data throughout trading hours, helping traders and investors stay informed with the latest technical analysis and trend information for 250+ NSE stocks.

Aurobindo Pharma Limited (Aurobindo Pharma) Technical Analysis Overview

This page brings together the most important technical indicators for Aurobindo Pharma Limited in one place. Instead of checking multiple charts, you can quickly review the stock's price action, trend, momentum, and key support and resistance levels from a single dashboard.

Whether you are an intraday trader, swing trader, or long-term investor, this page helps you quickly understand the current technical picture of Aurobindo Pharma before making your own investment decisions.

Disclaimer: TrendScreener.in is an educational stock analysis platform and is not a SEBI-registered Research Analyst or Investment Advisor. The information on this page is generated using technical indicators and market data and should not be considered as investment advice or buy/sell recommendations. Please do your own research before investing.